Clinical Pharmacology
Indications & Usage
CAREONE INFANTS ACETAMINOPHEN is listed as a SUSPENSION formulation in the SUSPENSION category. Consult official FDA labeling for full prescribing information.
Administration Context
CAREONE INFANTS ACETAMINOPHEN is administered via the ORAL route as a SUSPENSION.
Administration Protocol
Prescribing Information
Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.
Safety Profile
Contraindications & Warnings
Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.
National Drug Registry
Product and label metadata.
Marketing Category
OTC MONOGRAPH DRUG
Route of Administration
ORAL
National Drug Code
72476-766
Manufacturer / Labeler
Retail Business Services, LLC
Dosage Form
SUSPENSION
Strength
See labeling
Application Number
M013
SPL Identifier
a4a04fc6-e751-41a9-8344-8da41004a960
WHO Regulatory Intelligence
Vaccine Safety Information
Access evidence-based safety data and clinical guidelines from global health resources.